Diana supports and leads on the commercialisation of MedTech, and HealthTech related technologies from Imperial’s Faculty of Engineering and has supported on the licensing to spinout companies such as SPARTA Biodiscovery and Signatur Biosciences since joining Imperial in 2022. Prior to Imperial, Diana held various roles in Innovation and Strategy both in New Zealand and the UK, and most notably has a proven track record in supporting the growth of small and medium-sized enterprises at UCL Innovation & Enterprise.
Originally trained as Medical Laboratory Scientist in New Zealand’s largest tertiary hospital, she then obtained her MSc in Biomedical Science and a Postgraduate Diploma in Business Administration from the University of Auckland before moving to the UK.
